XML 296 R72.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders’ Deficiency (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Feb. 14, 2024
Feb. 09, 2024
Mar. 31, 2023
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Subsidiary, Sale of Stock [Line Items]              
Common stock authorized         1,000,000,000   1,000,000,000
Common stock par value         $ 0.01   $ 0.01
Stock Issued During Period, Shares, New Issues   5,000,000          
Share Price   $ 5.00         $ 2.38
Net proceeds from common stock         $ 12,000  
Offering costs         $ 69  
Common Stock [Member]              
Subsidiary, Sale of Stock [Line Items]              
Stock Issued During Period, Shares, New Issues         5,555,555    
Vesting of restricted stock units         678,165 397,376  
Common Stock [Member] | Restricted Stock Units (RSUs) [Member]              
Subsidiary, Sale of Stock [Line Items]              
Vesting of restricted stock units         678,165 397,376  
Stock Purchase Agreements [Member]              
Subsidiary, Sale of Stock [Line Items]              
Net proceeds from common stock     $ 11,211 $ 1,232      
Offering costs     289        
Stock Purchase Agreements [Member] | Purchasers [Member]              
Subsidiary, Sale of Stock [Line Items]              
Net proceeds from common stock     $ 11,500        
Sale of stock number of shares issued in transaction     2,963,918 317,518      
Sale of stock price per share     $ 3.88 $ 3.88   $ 3.88  
Private Placement [Member] | Subscription Agreement [Member]              
Subsidiary, Sale of Stock [Line Items]              
Share Price $ 2.16            
Net proceeds from common stock $ 12,000            
Private Placement [Member] | Subscription Agreement [Member] | Common Stock [Member]              
Subsidiary, Sale of Stock [Line Items]              
Stock Issued During Period, Shares, New Issues 5,555,555